Compare NNNN & OCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | OCC |
|---|---|---|
| Founded | 2021 | 1983 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Telecommunications Equipment |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.1M | 125.2M |
| IPO Year | 2023 | 2001 |
| Metric | NNNN | OCC |
|---|---|---|
| Price | $3.81 | $10.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 45.9K | ★ 96.8K |
| Earning Date | 11-24-2026 | 12-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 290.91 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $87,828,590.00 |
| Revenue This Year | N/A | $22.52 |
| Revenue Next Year | N/A | $18.51 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | N/A | ★ 37.03 |
| 52 Week Low | $3.09 | $4.02 |
| 52 Week High | $44.73 | $27.98 |
| Indicator | NNNN | OCC |
|---|---|---|
| Relative Strength Index (RSI) | 43.58 | 38.95 |
| Support Level | $3.21 | $9.07 |
| Resistance Level | $6.95 | $10.56 |
| Average True Range (ATR) | 0.35 | 0.93 |
| MACD | 0.13 | 0.02 |
| Stochastic Oscillator | 42.92 | 40.43 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Optical Cable Corp manufactures a broad range of fiber optic and copper data communication cabling and connectivity solutions for the enterprise, wireless carrier, and specialty markets. The Company offers high quality products that operate as a system solution or integrate with other components, including fiber, copper, hybrid cabling, cabinets, racks, enclosures, and deployable solutions for enterprise networks, data centers, residential, campus, Passive Optical LAN installations, and customized applications in military, industrial, mining, petrochemical, renewable energy, and broadcast industries. It operates a single reportable segment covering the design, development, manufacture, and marketing of its cabling and connectivity solutions.